TFF PHARMACEUTICALS INC's ticker is TFFP and the CUSIP is 87241J104. A total of 42 filers reported holding TFF PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,233 | -25.5% | 49,238 | 0.0% | 0.00% | – |
| Q2 2023 | $23,142 | -31.4% | 49,238 | 0.0% | 0.00% | – |
| Q1 2023 | $33,743 | -17.8% | 49,238 | +25.9% | 0.00% | – |
| Q4 2022 | $41,063 | -74.2% | 39,108 | 0.0% | 0.00% | – |
| Q3 2022 | $159,000 | -18.9% | 39,108 | +12.5% | 0.00% | – |
| Q2 2022 | $196,000 | -9.3% | 34,760 | +1.6% | 0.00% | – |
| Q1 2022 | $216,000 | -32.1% | 34,222 | -4.4% | 0.00% | – |
| Q4 2021 | $318,000 | -4.2% | 35,809 | -16.8% | 0.00% | – |
| Q3 2021 | $332,000 | +23.4% | 43,014 | +53.4% | 0.00% | – |
| Q2 2021 | $269,000 | -7.9% | 28,042 | +30.2% | 0.00% | – |
| Q1 2021 | $292,000 | -4.9% | 21,530 | +0.5% | 0.00% | – |
| Q4 2020 | $307,000 | -24.2% | 21,424 | -2.3% | 0.00% | – |
| Q3 2020 | $405,000 | – | 21,934 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,058,823 | $19,556,000 | 9.92% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 220,666 | $4,076,000 | 4.24% |
| Mesirow Financial Investment Management, Inc. | 34,902 | $645,000 | 2.76% |
| Gagnon Advisors, LLC | 176,471 | $3,259,000 | 2.00% |
| Nantahala Capital Management | 2,032,988 | $37,549,000 | 1.15% |
| PRECEPT MANAGEMENT LLC | 235,294 | $4,346,000 | 1.07% |
| GAGNON SECURITIES LLC | 219,584 | $4,056,000 | 0.86% |
| Sepio Capital, LP | 84,560 | $1,562,000 | 0.17% |
| 683 Capital Management, LLC | 117,647 | $2,173,000 | 0.16% |
| SANDERS MORRIS HARRIS LLC | 21,326 | $340,000 | 0.09% |